Revenue: The sum of all revenue fields included for a company's operating activities.
Abbott Laboratories (ABT) had Revenue of $8.85B for the most recently reported fiscal quarter, ending 2020-09-30.
Income Statement Financials | |
Revenue |
$8.85B |
$1.23B |
|
$3.97B |
|
$4.89B |
|
$7.36B |
|
$1.50B |
|
$-74.00M |
|
$1.42B |
|
$1.42B |
|
$1.23B |
|
$1.23B |
|
$1.23B |
|
$1.23B |
|
$1.50B |
|
$2.30B |
|
1.77B |
|
1.79B |
|
$0.69 |
|
$0.69 |
|
Balance Sheet Financials | |
$17.39B |
|
$8.62B |
|
$51.65B |
|
$69.04B |
|
$10.26B |
|
$18.35B |
|
$27.19B |
|
$37.45B |
|
$31.59B |
|
$-6.95B |
|
$31.59B |
|
1.77B |
|
Cash Flow Statement Financials | |
$4.10B |
|
$-1.48B |
|
$-1.99B |
|
$3.86B |
|
$4.48B |
|
$620.00M |
|
$448.00M |
|
$-1.92B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
0.37 |
|
0.59 |
|
55.20% |
|
16.89% |
|
16.89% |
|
-- |
|
16.05% |
|
13.92% |
|
$2.60B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.77 |
|
1.57 |
|
57.43 |
|
3.90% |
|
-17.72% |
|
1.78% |
|
2.47% |
|
$17.83 |
|
$1.46 |
|
$2.29 |